Developer docs
API playgroundTry for free, no card

Search company profiles

synlab Eesti OÜ

Full company profile

uuid000ydjr

Namestring
synlab Eesti OÜ
Legal namestring
SYNLAB Eesti OÜ
Websiteurl
synlab.ee
Company typeenum
Private
Founded yearint
2005
Descriptiontext

SYNLAB Eesti OÜ is the Estonian operating subsidiary of the pan-European SYNLAB Group, one of Europe's largest medical diagnostic laboratory networks (the parent is held by the A.P. Møller group following its acquisition from Cinven and other investors). The company provides medical diagnostic laboratory services across Estonia, spanning clinical chemistry, hematology, immunology, microbiology, molecular diagnostics, and genetic testing, including a flagship pharmacogenetics DNA panel that analyses 34 genes to predict drug metabolism for approximately 300 active pharmaceutical ingredients across 13 therapeutic areas. The pharmacogenetics panel runs on OpenArray and CNV analysis from EDTA blood or buccal swab samples with a 21 working-day turnaround, and is offered both to physicians (via integrated electronic ordering at 315 EUR under TK codes 66616/66610) and to private customers (at 325 EUR).

The business serves three primary customer segments with distinct go-to-market motions. Healthcare professionals (doctors, general practitioners, specialists) order electronically through Estonian physician software systems (Perearst2, Perearst3, LIISA, eKliinik, Watson/Winston, Ester/Heda, MIS) connected via the Medipost data exchange platform, with billing processed through health insurance reimbursement codes. Private individuals purchase tests directly through the Minu SYNLAB e-commerce portal (ee.minu.synlab.ee), which organises offerings into General Health, Nutrition, Sexual Health, Sport, Children, and "Test Yourself" home sampling categories, with sample collection available at nationwide phlebotomy points or via the mobile SYNLAB Bus. Employers are served through occupational health checks and corporate health days. SYNLAB Eesti also conducts scientific collaborations with the University of Tartu (KoroSero-EST seroepidemiological studies on 3,283 and 2,517 samples; KoroGeno-EST SARS-CoV-2 whole-genome sequencing) and the Health Development Institute on STI prevalence and nutrition biomarker studies, holds ISO 14001:2015 environmental certification, and maintains a patient insurance contract with Lloyd's Insurance Company S.A. (100,000 EUR per entitled person; 3,000,000 EUR per insurance period, valid 01.12.2025–30.11.2026).

Short descriptiontext

SYNLAB Eesti OÜ is the Estonian subsidiary of the pan-European SYNLAB Group, operating a nationwide medical diagnostic laboratory network that serves healthcare professionals (via integrated EHR ordering), private consumers (via the Minu SYNLAB e-commerce portal and SYNLAB Bus), and employers (occupational health services).

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersTallinn, Estonia
HQ citystring
Tallinn
HQ countrystring
Estonia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical diagnostic services, pharmacogenetics testing, clinical laboratory analysis, genetic health panels, occupational health screening
Industry3 codes
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAAAMAJ
Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Medical Diagnostic Laboratory Services
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Clinical Laboratory Testing Services
TypeSubscription Recurring
Description

Laboratory testing services for healthcare providers including clinical chemistry, hematology, immunology, microbiology, and genetic analyses. Revenue generated through health insurance reimbursements and direct patient/employer payments. Tests are billed using TK codes (e.g., 66616, 66610).

synlab.ee
2Direct-to-Consumer Genetic Testing
TypeOne Time License
Description

Private individuals purchase genetic tests directly through the Minu SYNLAB e-commerce platform including pharmacogenetics panels (325 EUR), microbiome tests (212 EUR), and other health panels. Results delivered via secure patient portal.

ee.minu.synlab.ee
3Occupational Health Services
TypeProfessional Services
Description

Pre-employment and preventive health check services for employers ( tööandjale ). Companies engage SYNLAB for workplace health assessments and organized health days.

synlab.ee
4Healthcare Professional Services
TypeSubscription Recurring
Description

Laboratory testing for medical professionals with electronic ordering through integrated physician software systems (Perearst2, Perearst3, LIISA, eKliinik, Watson/Winston, Ester/Heda, MIS).

synlab.ee
5Genetic Report Interpretation
TypeProfessional Services
Description

Interpretation service for pharmacogenetic test results available at 26 EUR, providing clinical guidance based on genetic profiles.

synlab.ee
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details5 tiers
1Farmakogeneetika uuring - Private customer genetic test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

325 EUR per pharmacogenetics DNA panel test for private individuals, including sample collection at SYNLAB points or SYNLAB Bus.

ee.minu.synlab.ee
2Farmakogeneetika DNA paneel - Healthcare provider ordered test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

315 EUR (TK codes 66616 and 66610×2) for healthcare professionals ordering for patients. Electronic ordering available through Medipost-integrated physician software.

synlab.ee
3Farmakogeneetika uuringu tõlgendamine - Genetic report interpretation
ModelUnit PricingBilling cadencePay-as-you-go
Notes

26 EUR for interpretation of pharmacogenetic test results by laboratory physician.

ee.minu.synlab.ee
4Mikrobioomi uuring - Microbiome test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

212 EUR for microbiome analysis test.

ee.minu.synlab.ee
5Küüne seenhaiguse uuring - Nail fungus test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

77.30 EUR for nail fungus disease testing.

ee.minu.synlab.ee
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

SYNLAB Eesti OÜ operates a medical diagnostic laboratory network in Estonia, providing clinical testing services to healthcare providers and private patients. Core offerings span clinical chemistry, hematology, immunology, microbiology, molecular diagnostics, genetic testing, and a flagship 34-gene pharmacogenetics DNA panel for personalized medication selection covering approximately 300 active pharmaceutical ingredients. Services are delivered through physical blood collection points, a mobile SYNLAB Bus, an electronic physician ordering platform, and the direct-to-consumer Minu SYNLAB portal.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • SARS-CoV-2 antibodies persist in approximately 80% of individuals 6-8 months after asymptomatic COVID-19
+2 more records
Product overview1 text field

SYNLAB Eesti OÜ operates a medical diagnostic laboratory network providing clinical testing services to healthcare providers and private patients across Estonia. The core offering is organized around the Minu SYNLAB self-service portal (ee.minu.synlab.ee) for patients, and a physician-facing service platform (synlab.ee/arstile) for healthcare professionals who order tests electronically. The Minu SYNLAB portal distributes testing across several consumer-facing service categories — General Health (Üldtervis), Nutrition (Toitumine), Sexual Health (Seksuaaltervis), Sport, Children (Lapsed) — alongside a 'Test Yourself' (TESTI ISE) home sampling option, consultation services, and gift cards. The flagship clinical product is the Farmakogeneetika DNA paneel, a pharmacogenetics panel that analyzes 34 genes to guide personalized drug selection and dosing across ~300 active pharmaceutical ingredients in 13 therapeutic areas. SYNLAB also maintains a molecular biology laboratory for pharmacogenetics testing, blood collection points throughout Estonia, a SYNLAB Bus mobile sampling service, and a training center (Koolituskeskus) for professional education.

Product and service2 records
1Farmakogeneetika DNA paneel (Pharmacogenetics DNA Panel)
CategoryPharmacogenetics and Genetic Testing
Description

A DNA-based pharmacogenetics panel analyzing 34 genes to predict patient drug metabolism phenotypes and guide personalized selection and dosing of approximately 300 active pharmaceutical ingredients across 13 therapeutic areas (dermatology, respiratory, anti-infectives, cardiovascular, oncology, sensory organs, neurology, parasitology, gastrointestinal, musculoskeletal, hormones, genitourinary, blood). The test uses OpenArray and CNV analysis from EDTA blood or buccal swab samples with results delivered in 21 working days. Available to physicians via electronic prescribing systems integrated with Medipost and to private patients through Minu SYNLAB.

2Minu SYNLAB Patient Self-Service Portal
CategoryDirect-to-Consumer Patient Portal Platform
Description

A web-based self-service portal (ee.minu.synlab.ee) through which private patients can purchase individual tests and health packages, schedule sample collection appointments at SYNLAB phlebotomy points or the SYNLAB Bus, access test results, and book physician consultations. The portal organizes services into categories: General Health, Nutrition, Sexual Health, Sport, Children, and 'Test Yourself' (TESTI ISE) home sampling kits. A separate Minu SYNLAB results viewer (results.minu.synlab.ee) delivers test results with explanatory content.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
1Estonian Olympic Committee (Eesti Olümpiakomitee)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SYNLAB provides free COVID-19 testing for Team Estonia Olympic athletes preparing for Summer and Winter Olympic Games, supporting their competitive preparation.

synlab.ee
2Estonian Paralympic Committee and Special Olympics Estonia
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Free COVID-19 testing services for Paralympic and Special Olympics athletes to enable their participation in international competitions.

synlab.ee
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple cooperation projects on sexually transmitted infection prevalence studies in risk groups, HIV testing and counseling in Tallinn and Tartu, and nutrition research including vegetarian and salt consumption studies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Seroepidemiological studies KoroSero-EST (1-3) analyzing SARS-CoV-2 antibody prevalence and KoroGeno-EST whole genome sequencing research. SYNLAB provides laboratory analysis of blood samples and contributes expertise.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Free COVID-19 testing for actors, musicians, and cultural professionals to enable virus-free cultural events in Estonia.

6SportEST - Movement Health Innovation Cluster
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in sports medicine development including training, conferences, new service development, and health awareness activities in Estonia.

synlab.ee
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Annual free health checks provided for all substitute parents, supporting the organization's family care mission.

8Estonian Sports Federations (Swimming, Biathlon, Skiing, Triathlon)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research on elite athletes' blood markers, free laboratory analyses, and laboratory physician consultations supporting Estonian sports development.

synlab.ee
9Society of STI (STLIEÜ)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cooperation on conferences and field development events for sexual health and STI prevention in Estonia.

synlab.ee
10Social Insurance Board (Sotsiaalkindlustusamet)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership to support nursing homes with donations of tablet computers and specialized mattresses for residents.

synlab.ee
Strategic tierCoreTypeTechnology or Integration
Description

Technology integration enabling electronic test ordering and results delivery through physician software systems (Perearst2, Perearst3, LIISA, eKliinik, Watson/Winston, Ester/Heda, MIS).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

LetsGetChecked is a DTC diagnostics company offering home self-collection kits, online ordering, and digital result delivery across multiple European markets. Its consumer-driven model and home-sampling logistics directly parallel SYNLAB Eesti's Minu SYNLAB portal and TESTI ISE home-sampling service.

TypeBroad incumbent
Description

Cerba Healthcare is a European clinical laboratory network focused on specialty and esoteric testing across multiple countries. Its emphasis on advanced diagnostics, reference testing, and hospital partnerships makes it a relevant comparable for SYNLAB Eesti's higher-margin esoteric and pharmacogenetics services.

TypeDirect peer
Description

Unilabs is one of Europe's largest clinical laboratory and diagnostic networks, operating in 16+ countries with a comparable menu of clinical chemistry, genetics, pharmacogenetics, and specialty testing. It is the most direct pan-European competitor to SYNLAB and a key reference for cross-border testing and esoteric service positioning.

TypeBroad incumbent
Description

Medicover operates integrated diagnostic laboratory and healthcare services across Central and Eastern Europe, including the Baltics and Nordics. Its regional diagnostic service offering, employer health programs, and DTC consumer channels directly overlap with SYNLAB Eesti's three-segment model in adjacent geographies.

TypeRegional player
Description

Tartu University Hospital operates one of Estonia's largest in-hospital clinical laboratories, providing routine and specialty testing primarily within the public healthcare system. It is the principal domestic institutional competitor for physician-ordered diagnostic volume in Estonia.

TypeDirect peer
Description

Synlab Finland is the Finnish sibling subsidiary of SYNLAB Eesti within SYNLAB Group. It operates the same clinical chemistry, immunology, genetics, and pharmacogenetics service portfolio for healthcare providers and private customers in Finland, making it the closest functional and operational comparable for benchmarking the Estonian entity.

TypeEmerging player
Description

Helix operates a population genomics and clinical-grade genetic testing platform with a focus on pharmacogenomics and consumer-driven health insights. It is a relevant emerging comparable for SYNLAB Eesti's DTC and pharmacogenetics positioning, particularly as personalized medicine adoption scales.

TypeDirect peer
Description

SYNLAB Group is the direct parent company of SYNLAB Eesti and operates one of Europe's largest medical diagnostic laboratory networks across ~30 countries. The Group's centralized assay development, reference testing capabilities, and pan-European commercial platform are directly leveraged by SYNLAB Eesti for its esoteric and routine diagnostic offerings.

TypeBroad incumbent
Description

Eurofins is a global laboratory testing group with strong European presence across clinical diagnostics, genetics, and biomarker testing. It competes with SYNLAB Eesti for advanced esoteric and genomic testing referrals and provides a comparable reference for assay menu breadth and scientific service positioning.

10North Estonia Medical Centre (PERH) Laboratory
TypeRegional player
Description

North Estonia Medical Centre operates a major hospital-based clinical laboratory in Tallinn serving the largest Estonian hospital catchment area. It is a primary institutional competitor to SYNLAB Eesti for public and hospital-channel diagnostic testing in the capital region.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

synlab Eesti OÜ

Medical Diagnostic Laboratory Servicessynlab.ee

SYNLAB Eesti OÜ is the Estonian subsidiary of the pan-European SYNLAB Group, operating a nationwide medical diagnostic laboratory network that serves healthcare professionals (via integrated EHR ordering), private consumers (via the Minu SYNLAB e-commerce portal and SYNLAB Bus), and employers (occupational health services).

What synlab Eesti OÜ does

SYNLAB Eesti OÜ is the Estonian operating subsidiary of the pan-European SYNLAB Group, one of Europe's largest medical diagnostic laboratory networks (the parent is held by the A.P. Møller group following its acquisition from Cinven and other investors). The company provides medical diagnostic laboratory services across Estonia, spanning clinical chemistry, hematology, immunology, microbiology, molecular diagnostics, and genetic testing, including a flagship pharmacogenetics DNA panel that analyses 34 genes to predict drug metabolism for approximately 300 active pharmaceutical ingredients across 13 therapeutic areas. The pharmacogenetics panel runs on OpenArray and CNV analysis from EDTA blood or buccal swab samples with a 21 working-day turnaround, and is offered both to physicians (via integrated electronic ordering at 315 EUR under TK codes 66616/66610) and to private customers (at 325 EUR).

The business serves three primary customer segments with distinct go-to-market motions. Healthcare professionals (doctors, general practitioners, specialists) order electronically through Estonian physician software systems (Perearst2, Perearst3, LIISA, eKliinik, Watson/Winston, Ester/Heda, MIS) connected via the Medipost data exchange platform, with billing processed through health insurance reimbursement codes. Private individuals purchase tests directly through the Minu SYNLAB e-commerce portal (ee.minu.synlab.ee), which organises offerings into General Health, Nutrition, Sexual Health, Sport, Children, and "Test Yourself" home sampling categories, with sample collection available at nationwide phlebotomy points or via the mobile SYNLAB Bus. Employers are served through occupational health checks and corporate health days. SYNLAB Eesti also conducts scientific collaborations with the University of Tartu (KoroSero-EST seroepidemiological studies on 3,283 and 2,517 samples; KoroGeno-EST SARS-CoV-2 whole-genome sequencing) and the Health Development Institute on STI prevalence and nutrition biomarker studies, holds ISO 14001:2015 environmental certification, and maintains a patient insurance contract with Lloyd's Insurance Company S.A. (100,000 EUR per entitled person; 3,000,000 EUR per insurance period, valid 01.12.2025–30.11.2026).

synlab Eesti OÜ firmographics

Firmographics
Name
synlab Eesti OÜ
Legal name
SYNLAB Eesti OÜ
Website
https://synlab.ee
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Short description
SYNLAB Eesti OÜ is the Estonian subsidiary of the pan-European SYNLAB Group, operating a nationwide medical diagnostic laboratory network that serves healthcare professionals (via integrated EHR ordering), private consumers (via the Minu SYNLAB e-commerce portal and SYNLAB Bus), and employers (occupational health services).
Ownership category
akta.pro rank

synlab Eesti OÜ industry classification

Industry
Product category
Medical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAAAMAJ
Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Medical diagnostic services
  • Pharmacogenetics testing
  • Clinical laboratory analysis
  • Genetic health panels
  • Occupational health screening

Where synlab Eesti OÜ is headquartered

Location

Headquarters

HQ city
Tallinn
HQ country
Estonia
HQ region
Europe

Offices1 record

Markets served

synlab Eesti OÜ business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Clinical Laboratory Testing Services: Laboratory testing services for healthcare providers including clinical chemistry, hematology, immunology, microbiology, and genetic analyses. Revenue generated through health insurance reimbursements and direct patient/employer payments. Tests are billed using TK codes (e.g., 66616, 66610).
  2. Direct-to-Consumer Genetic Testing: Private individuals purchase genetic tests directly through the Minu SYNLAB e-commerce platform including pharmacogenetics panels (325 EUR), microbiome tests (212 EUR), and other health panels. Results delivered via secure patient portal.
  3. Occupational Health Services: Pre-employment and preventive health check services for employers ( tööandjale ). Companies engage SYNLAB for workplace health assessments and organized health days.
  4. Healthcare Professional Services: Laboratory testing for medical professionals with electronic ordering through integrated physician software systems (Perearst2, Perearst3, LIISA, eKliinik, Watson/Winston, Ester/Heda, MIS).
  5. Genetic Report Interpretation: Interpretation service for pharmacogenetic test results available at 26 EUR, providing clinical guidance based on genetic profiles.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goFarmakogeneetika uuring - Private customer genetic test
Unit PricingPay-as-you-goFarmakogeneetika DNA paneel - Healthcare provider ordered test
Unit PricingPay-as-you-goFarmakogeneetika uuringu tõlgendamine - Genetic report interpretation
One time/ perpetual licensePay-as-you-goMikrobioomi uuring - Microbiome test
Unit PricingPay-as-you-goKüüne seenhaiguse uuring - Nail fungus test

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

synlab Eesti OÜ product offering

Product offering

Core offering

SYNLAB Eesti OÜ operates a medical diagnostic laboratory network in Estonia, providing clinical testing services to healthcare providers and private patients. Core offerings span clinical chemistry, hematology, immunology, microbiology, molecular diagnostics, genetic testing, and a flagship 34-gene pharmacogenetics DNA panel for personalized medication selection covering approximately 300 active pharmaceutical ingredients. Services are delivered through physical blood collection points, a mobile SYNLAB Bus, an electronic physician ordering platform, and the direct-to-consumer Minu SYNLAB portal.

Product overview

SYNLAB Eesti OÜ operates a medical diagnostic laboratory network providing clinical testing services to healthcare providers and private patients across Estonia. The core offering is organized around the Minu SYNLAB self-service portal (ee.minu.synlab.ee) for patients, and a physician-facing service platform (synlab.ee/arstile) for healthcare professionals who order tests electronically. The Minu SYNLAB portal distributes testing across several consumer-facing service categories — General Health (Üldtervis), Nutrition (Toitumine), Sexual Health (Seksuaaltervis), Sport, Children (Lapsed) — alongside a 'Test Yourself' (TESTI ISE) home sampling option, consultation services, and gift cards. The flagship clinical product is the Farmakogeneetika DNA paneel, a pharmacogenetics panel that analyzes 34 genes to guide personalized drug selection and dosing across ~300 active pharmaceutical ingredients in 13 therapeutic areas. SYNLAB also maintains a molecular biology laboratory for pharmacogenetics testing, blood collection points throughout Estonia, a SYNLAB Bus mobile sampling service, and a training center (Koolituskeskus) for professional education.

Differentiator

Problem solved

Functional benefit

Products and services

  • Farmakogeneetika DNA paneel (Pharmacogenetics DNA Panel) A DNA-based pharmacogenetics panel analyzing 34 genes to predict patient drug metabolism phenotypes and guide personalized selection and dosing of approximately 300 active pharmaceutical ingredients across 13 therapeutic areas (dermatology, respiratory, anti-infectives, cardiovascular, oncology, sensory organs, neurology, parasitology, gastrointestinal, musculoskeletal, hormones, genitourinary, blood). The test uses OpenArray and CNV analysis from EDTA blood or buccal swab samples with results delivered in 21 working days. Available to physicians via electronic prescribing systems integrated with Medipost and to private patients through Minu SYNLAB.
  • Minu SYNLAB Patient Self-Service Portal A web-based self-service portal (ee.minu.synlab.ee) through which private patients can purchase individual tests and health packages, schedule sample collection appointments at SYNLAB phlebotomy points or the SYNLAB Bus, access test results, and book physician consultations. The portal organizes services into categories: General Health, Nutrition, Sexual Health, Sport, Children, and 'Test Yourself' (TESTI ISE) home sampling kits. A separate Minu SYNLAB results viewer (results.minu.synlab.ee) delivers test results with explanatory content.

Quantifiable outcome

  • SARS-CoV-2 antibodies persist in approximately 80% of individuals 6-8 months after asymptomatic COVID-19
  • +2 more outcomes

Companies that use synlab Eesti OÜ

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles4 records

synlab Eesti OÜ technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

synlab Eesti OÜ partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Estonian Olympic Committee (Eesti Olümpiakomitee)coreStrategic or Co-development PartnerSYNLAB provides free COVID-19 testing for Team Estonia Olympic athletes preparing for Summer and Winter Olympic Games, supporting their competitive preparation.
  • Estonian Paralympic Committee and Special Olympics EstoniacoreStrategic or Co-development PartnerFree COVID-19 testing services for Paralympic and Special Olympics athletes to enable their participation in international competitions.
  • Health Development Institute (Tervise Arengu Instituut)coreStrategic or Co-development PartnerMultiple cooperation projects on sexually transmitted infection prevalence studies in risk groups, HIV testing and counseling in Tallinn and Tartu, and nutrition research including vegetarian and salt consumption studies.
  • University of Tartu - Institute of Biomedicine and Translational MedicinecoreStrategic or Co-development PartnerSeroepidemiological studies KoroSero-EST (1-3) analyzing SARS-CoV-2 antibody prevalence and KoroGeno-EST whole genome sequencing research. SYNLAB provides laboratory analysis of blood samples and contributes expertise.
  • Estonian Association of Performing Arts Organizations (Eesti Etendusasutuste Liit)minorStrategic or Co-development PartnerFree COVID-19 testing for actors, musicians, and cultural professionals to enable virus-free cultural events in Estonia.
  • SportEST - Movement Health Innovation ClusterminorStrategic or Co-development PartnerPartner in sports medicine development including training, conferences, new service development, and health awareness activities in Estonia.
  • SOS Children's Village Estonia (SOS Lasteküla Eesti Ühing)minorStrategic or Co-development PartnerAnnual free health checks provided for all substitute parents, supporting the organization's family care mission.
  • Estonian Sports Federations (Swimming, Biathlon, Skiing, Triathlon)minorStrategic or Co-development PartnerResearch on elite athletes' blood markers, free laboratory analyses, and laboratory physician consultations supporting Estonian sports development.
  • Society of STI (STLIEÜ)minorStrategic or Co-development PartnerCooperation on conferences and field development events for sexual health and STI prevention in Estonia.
  • Social Insurance Board (Sotsiaalkindlustusamet)minorStrategic or Co-development PartnerPartnership to support nursing homes with donations of tablet computers and specialized mattresses for residents.
  • Medipost Data Exchange PlatformcoreTechnology or IntegrationTechnology integration enabling electronic test ordering and results delivery through physician software systems (Perearst2, Perearst3, LIISA, eKliinik, Watson/Winston, Ester/Heda, MIS).

Scale indicators5 records

Recent moves6 records

Expansion highlights7 records

synlab Eesti OÜ competitors and assessment

Company assessment

Emerging players

  • LetsGetChecked: LetsGetChecked is a DTC diagnostics company offering home self-collection kits, online ordering, and digital result delivery across multiple European markets. Its consumer-driven model and home-sampling logistics directly parallel SYNLAB Eesti's Minu SYNLAB portal and TESTI ISE home-sampling service.
  • Helix: Helix operates a population genomics and clinical-grade genetic testing platform with a focus on pharmacogenomics and consumer-driven health insights. It is a relevant emerging comparable for SYNLAB Eesti's DTC and pharmacogenetics positioning, particularly as personalized medicine adoption scales.

Broad incumbents

  • Cerba Healthcare: Cerba Healthcare is a European clinical laboratory network focused on specialty and esoteric testing across multiple countries. Its emphasis on advanced diagnostics, reference testing, and hospital partnerships makes it a relevant comparable for SYNLAB Eesti's higher-margin esoteric and pharmacogenetics services.
  • Medicover: Medicover operates integrated diagnostic laboratory and healthcare services across Central and Eastern Europe, including the Baltics and Nordics. Its regional diagnostic service offering, employer health programs, and DTC consumer channels directly overlap with SYNLAB Eesti's three-segment model in adjacent geographies.
  • Eurofins Genomics: Eurofins is a global laboratory testing group with strong European presence across clinical diagnostics, genetics, and biomarker testing. It competes with SYNLAB Eesti for advanced esoteric and genomic testing referrals and provides a comparable reference for assay menu breadth and scientific service positioning.

Direct peers

  • Unilabs: Unilabs is one of Europe's largest clinical laboratory and diagnostic networks, operating in 16+ countries with a comparable menu of clinical chemistry, genetics, pharmacogenetics, and specialty testing. It is the most direct pan-European competitor to SYNLAB and a key reference for cross-border testing and esoteric service positioning.
  • Synlab Finland: Synlab Finland is the Finnish sibling subsidiary of SYNLAB Eesti within SYNLAB Group. It operates the same clinical chemistry, immunology, genetics, and pharmacogenetics service portfolio for healthcare providers and private customers in Finland, making it the closest functional and operational comparable for benchmarking the Estonian entity.
  • SYNLAB Group: SYNLAB Group is the direct parent company of SYNLAB Eesti and operates one of Europe's largest medical diagnostic laboratory networks across ~30 countries. The Group's centralized assay development, reference testing capabilities, and pan-European commercial platform are directly leveraged by SYNLAB Eesti for its esoteric and routine diagnostic offerings.

Regional players

  • Tartu University Hospital Laboratory: Tartu University Hospital operates one of Estonia's largest in-hospital clinical laboratories, providing routine and specialty testing primarily within the public healthcare system. It is the principal domestic institutional competitor for physician-ordered diagnostic volume in Estonia.
  • North Estonia Medical Centre (PERH) Laboratory: North Estonia Medical Centre operates a major hospital-based clinical laboratory in Tallinn serving the largest Estonian hospital catchment area. It is a primary institutional competitor to SYNLAB Eesti for public and hospital-channel diagnostic testing in the capital region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks1 record

Key highlights6 records

Customer concentration

synlab Eesti OÜ compliance and trust

Trust signal

Compliance2 records

synlab Eesti OÜ financial estimates

Financial estimate

Revenue estimate

Valuation estimate

synlab Eesti OÜ leadership team

Management profile

Number of profiles

synlab Eesti OÜ funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

synlab Eesti OÜ M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about synlab Eesti OÜ

What does synlab Eesti OÜ do?

SYNLAB Eesti OÜ operates a medical diagnostic laboratory network in Estonia, providing clinical testing services to healthcare providers and private patients. Core offerings span clinical chemistry, hematology, immunology, microbiology, molecular diagnostics, genetic testing, and a flagship 34-gene pharmacogenetics DNA panel for personalized medication selection covering approximately 300 active pharmaceutical ingredients. Services are delivered through physical blood collection points, a mobile SYNLAB Bus, an electronic physician ordering platform, and the direct-to-consumer Minu SYNLAB portal.

Is synlab Eesti OÜ a public or private company?

synlab Eesti OÜ is a private company. It is classified as corporate owned and is currently operating.

When was synlab Eesti OÜ founded?

synlab Eesti OÜ was founded in 2005. It employs 51 to 100 people.

Where is synlab Eesti OÜ based?

synlab Eesti OÜ is headquartered in Tallinn, Estonia, in the Europe region.

How does synlab Eesti OÜ make money?

Five revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are direct-to-Consumer Genetic Testing, occupational Health Services, healthcare Professional Services and genetic Report Interpretation.

Who are synlab Eesti OÜ's main competitors?

Emerging players on record are LetsGetChecked and Helix. Broad incumbents are Cerba Healthcare, Medicover and Eurofins Genomics. Direct peers are Unilabs, Synlab Finland and SYNLAB Group. Regional players are Tartu University Hospital Laboratory and North Estonia Medical Centre (PERH) Laboratory.

Does synlab Eesti OÜ have an API?

No public API is recorded for synlab Eesti OÜ.

What industry is synlab Eesti OÜ in?

synlab Eesti OÜ's product category is Medical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAAAMAJ, Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales